SCHEMBL628056

SCHEMBL628056

FC(F)(F)c1cc(Cl)nc(Cl)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NT5E P21589 2/20 0.39
ALDH1A1 P00352 5/20 0.38
KDM4E B2RXH2 5/20 0.38
HSD17B10 Q99714 2/20 0.38
HSP90AA1 P07900 1/20 0.38
HSP90AB1 P08238 1/20 0.38
ADORA2A P29274 2/20 0.36
ADORA1 P30542 1/20 0.36
ATF1 P18846 1/20 0.36
NFKB1 P19838 1/20 0.36
HIF1A Q16665 1/20 0.35
TAS2R14 Q9NYV8 1/20 0.35
TSHR P16473 2/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CRHBP P24387 1/20 0.33
CYP2C19 P33261 1/20 0.33
CRHR2 Q13324 1/20 0.33
ALOX15 P16050 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6468496 0.87 NT5E (0.42) NT5EALDH1A1KDM4EHSD17B10HSP90AA1
SCHEMBL26685429 0.84 HRH4 (0.36) ALDH1A1ATF1NFKB1TSHRCYP2C19
SCHEMBL10558546 0.84 ATF1 (0.33) ALDH1A1ATF1NFKB1TSHRCYP3A4
SCHEMBL30632784 0.84 HRH4 (0.36) ALDH1A1ATF1NFKB1TSHRCYP2C19
SCHEMBL10555728 0.84 ATF1 (0.33) ALDH1A1ATF1NFKB1TSHRCYP3A4
SCHEMBL30809049 0.82 HRH4 (0.35) ATF1NFKB1CYP2C19
SCHEMBL113146 0.82 HRH4 (0.35) ATF1NFKB1CYP2C19
SCHEMBL6294671 0.79 NT5E (0.38) NT5EALDH1A1KDM4EHSD17B10HSP90AA1
SCHEMBL2423979 0.78 TSHR (0.43) ALDH1A1ATF1NFKB1TSHRCYP3A4
SCHEMBL16280022 0.78 PDE4D (0.42) ALDH1A1KDM4EHSD17B10ATF1NFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 385 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110951051-B Preparation method and application of thermotropic delayed fluorescence copolymer with side chain containing trifluoromethyl pyrimidine 大连理工大学 2021-04-20 CN claimed
CN-110951051-A Preparation method and application of thermotropic delayed fluorescence copolymer with side chain containing trifluoromethyl pyrimidine 大连理工大学 2020-04-03 CN claimed
EP-2213663-B1 Preparation of halogenated N-heteroaromatic polyhalogen derivatives SALTIGO GMBH (DE) 2011-09-28 EP claimed
EP-2213663-A1 Preparation of halogenated N-heteroaromatic polyhalogen derivatives Saltigo GmbH (DE) 2010-08-04 EP claimed
US-12637436-B2 Metabotropic glutamate receptor negative allosteric modulators (NAMs) and uses thereof Sanford Burnham Prebys Medical Discovery Institute (US) 2026-05-26 US disclosed
US-12637440-B2 Amide derivative useful as diacylglycerol acyltransferase 2 inhibitor, and use thereof LG CHEM, LTD. (KR) 2026-05-26 US disclosed
US-12630528-B2 Amino aryl derivative useful as diacylglycerol acyltransferase 2 inhibitor and use thereof LG CHEM, LTD. (KR) 2026-05-19 US disclosed
EP-4731623-A1 CARBOLINE COMPOUNDS AND USE THEREOF PTC Therapeutics, Inc. (US) 2026-04-29 EP disclosed
US-12611401-B2 Combinations comprising benzodioxol as GLP-1R agonists for use in the treatment of NASH/NAFLD and related diseases PFIZER INC. (US) 2026-04-28 US disclosed
EP-4695239-A1 DISUBSTITUTED PYRIMIDINE COMPOUNDS FOR KETOHEXOKINASE INHIBITION Centennial Therapeutics, LLC (US) 2026-02-18 EP disclosed
US-20260035367-A1 PKC-Theta Modulators CELGENE CORPORATION (US) 2026-02-05 US disclosed
EP-4685141-A1 ISOINDOLINE DERIVATIVE, BENZOINDOLE DERIVATIVE AND USE THEREOF Shanghai Helioson Pharmaceutical Co., Ltd. (CN) 2026-01-28 EP disclosed
US-20090093480-A1 INSECTICIDAL PYRIMIDINYL ARYL HYRDRAZONES DOW AGROSCIENCES LLC (US) 2009-04-09 US disclosed
US-20090093480-A1 INSECTICIDAL PYRIMIDINYL ARYL HYRDRAZONES DOW AGROSCIENCES LLC (US) 2009-04-09 US disclosed
US-20080119535-A1 AMINOMETHYL-4-IMIDAZOLES F. HOFFMANN-LA ROCHE AG (CH) 2008-05-22 US disclosed
WO-2008046757-A1 AMINOMETHYL-4-IMIDAZOLES F. HOFFMANN-LA ROCHE AG (CH) 2008-04-24 WO disclosed
US-20060172994-A1 Compounds useful as chemokine receptor antagonists MILLENNIUM PHARMACEUTICALS, INC. 2006-08-03 US disclosed
WO-2006071875-A1 COMPOUNDS USEFUL AS CHEMOKINE RECEPTOR ANTAGONISTS MILLENNIUM PHARMACEUTICALS, INC. (US) 2006-07-06 WO disclosed
US-4877443-A 2,4-diamino-6-trifluoromethylpyrimidine compounds useful as herbicides BAYER AKTIENGESELLSCHAFT (DE) 1989-10-31 US disclosed
EP-0230244-A2 2,4-Diamino-6-halogenoalkyl pyrimidines BAYER AG (DE) 1987-07-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090093480-A1 INSECTICIDAL PYRIMIDINYL ARYL HYRDRAZONES DDT, HELZ, HPD NT5E 3363/4885ALDH1A1 802/4885KDM4E 2517/4885
US-20060172994-A1 Compounds useful as chemokine receptor antagonists ACKR3, CCR5, CXCR2 NT5E 570/4885ALDH1A1 1901/4885KDM4E 4645/4885
US-20260035367-A1 PKC-Theta Modulators PRKAR2B, PRKAR2A, PRKCD NT5E 4105/4885ALDH1A1 4459/4885KDM4E 4598/4885
US-20080119535-A1 AMINOMETHYL-4-IMIDAZOLES INMT, HTR4, MC4R NT5E 3185/4885ALDH1A1 631/4885KDM4E 69/4885
US-12630528-B2 Amino aryl derivative useful as diacylglycerol acyltransferase 2 inhibitor and use thereof DGAT2, DGAT1, SOAT2 NT5E 3672/4885ALDH1A1 597/4885KDM4E 2839/4885
US-12611401-B2 Combinations comprising benzodioxol as GLP-1R agonists for use in the treatment of NASH/NAFLD and related diseases GLP1R, GCKR, GPR119 NT5E 3646/4885ALDH1A1 743/4885KDM4E 899/4885
US-12637440-B2 Amide derivative useful as diacylglycerol acyltransferase 2 inhibitor, and use thereof DGAT2, DGAT1, DLAT NT5E 3162/4885ALDH1A1 885/4885KDM4E 3064/4885
US-12637436-B2 Metabotropic glutamate receptor negative allosteric modulators (NAMs) and uses thereof GRM3, GRM2, GRM1 NT5E 2267/4885ALDH1A1 3385/4885KDM4E 1949/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.